Brittany Rodgers
Child & Adolescent Psychiatry · Greenville, SCNPI 1336439637
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $746 and has fallen 95.4% since, to $34 in 2024.
Across 151 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$530
- Johnson & Johnson$361
- Sunovion Pharmaceuticals Inc.$349
- Takeda Pharmaceuticals U.S.A., Inc.$303
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$217
- Supernus Pharmaceuticals, Inc.$104
- plus $769 from 14 others
What the payments were for
- Food & beverage$2,634100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 33 | $530 |
| Johnson & Johnson | 17 | $361 |
| Sunovion Pharmaceuticals Inc. | 17 | $349 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $303 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $217 |
| Supernus Pharmaceuticals, Inc. | 7 | $104 |
| Neurocrine Biosciences, Inc. | 6 | $103 |
| Otsuka America Pharmaceutical, Inc. | 6 | $95 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| AbbVie(2 entities) | 6 | $82 |
| Tris Pharma Inc | 4 | $73 |
| Corium, LLC | 4 | $73 |
| Neos Therapeutics, LP | 4 | $64 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Alkermes, Inc. | 2 | $37 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Neuronetics, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$106
How this compares
$2,634 in reported general payments places this provider in the 80th percentile of 71 child & adolescent psychiatry providers in South Carolina.
See all child & adolescent psychiatry providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 16 | $594 |
| Oxcarbazepine | 20 | $227 |
| Lamotrigine | 27 | $203 |
| Clonazepam | 12 | $128 |
| Alprazolam | 17 | $94 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Greenville
- David SherbondyGreenville$19K
- Elena DlugachGreenville$8K
- Elizabeth MasonGreenville$1K
- Deborah DavisGreenville$999
- Leah McCarttGreenville$658
- Michael SierraGreenville$483
- Amy JonesGreenville$282
- Sara Infield LavelleGreenville$224
- Lance FeldmanGreenville$190
- Dinorah GomezGreenville$150
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.